Your session is about to expire
← Back to Search
Enobosarm Monotherapy for Breast Cancer (ARTEST Trial)
ARTEST Trial Summary
This trial is testing a new drug to see if it can improve survival in patients with metastatic breast cancer.
ARTEST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 trial • 18 Patients • NCT02971761ARTEST Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Enobosarm is often used for what reason?
"Enobosarm is an effective therapy for postmenopause, advance directives, and 2-3 years of tamoxifen."
Are there any available openings for new recruits in this research project?
"Yes, this trial is still open and recruiting patients according to the information on clinicaltrials.gov. The listing was created on 12th October 2021 and updated 14th October 2022."
Could you explain the possible risks associated with taking Enobosarm?
"Enobosarm's safety is estimated to be a 3. This rating comes from the fact that Enobosarm is in Phase 3 trials, meaning there is both evidence of efficacy and multiple rounds of data supporting safety."
Could I qualify to take part in this research?
"This clinical trial is recruiting 210 people, within the ages of 18 and 100 who have malignant neoplasms. It is required that patients also meet the following criteria: Age <55 years and surgical menopause with bilateral oophorectomy, For Female Subjects, Menopausal status, Be able to communicate effectively with the study personnel, Age ≥55 years and one year or more of amenorrhea, Aged ≥18 years."
Does this Phase III study include patients that are middle-aged?
"The age limit for this particular trial is 18 to 100. However, there are 68 other trials that cater to patients under the age of 18 and 2356 clinical trials for individuals over 65 years old."
In how many different hospitals is this research project being conducted?
"At the time of this writing, patients are being accepted at 38 different locations including Virginia Oncology Associates in Norfolk, Virginia, Tidelands Health in Murrells Inlet, South carolina, and Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio."
Is Enobosarm a new medication or has it been studied before?
"As of now, there are 61 different clinical trials researching Enobosarm. Out of those, 23 are in Phase 3. Even though a large number of the trials for Enobosarm originate in Pisa, PI, there are 7747 total locations running these studies."
Share this study with friends
Copy Link
Messenger